BETH ISRAEL DEACONESS MEDICAL CENTER
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 1896-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.bidmc.org/
Memory Aid by Intranasal Insulin in Diabetes (MemAID)
Phase 2
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Drug: Regular Human InsulinDrug: Placebo
- First Posted Date
- 2015-04-14
- Last Posted Date
- 2022-05-19
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 289
- Registration Number
- NCT02415556
- Locations
- πΊπΈ
Vera Novak, Boston, Massachusetts, United States
πΊπΈBrigham and Women's Hospital, Boston, Massachusetts, United States
Lorcaserin in Obesity: Identification of CNS Targets Using FMRI
Phase 4
Active, not recruiting
- Conditions
- Weight LossObesity
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-03-27
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02400359
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Ultrasound Guided Femoral Nerve Block
Not Applicable
Recruiting
- Conditions
- Hip Fracture
- Interventions
- First Posted Date
- 2015-03-06
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT02381717
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
πΊπΈSt. Vincent's Hospital, Worcester, Massachusetts, United States
Esmolol to Treat the Hemodynamic Effects of Septic Shock
Phase 2
Terminated
- Conditions
- Septic ShockTachycardiaHypotension
- Interventions
- Other: Saline
- First Posted Date
- 2015-02-24
- Last Posted Date
- 2021-06-28
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02369900
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Mechanisms of Weight Loss With SGLT2 Inhibition
Phase 4
Completed
- Conditions
- Type 2 DiabetesOverweightObesity
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-02-11
- Last Posted Date
- 2018-08-03
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT02360774
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Hematoma Block for Distal Radius Fracture
Not Applicable
Recruiting
- Conditions
- Distal Radius Fracture
- Interventions
- Other: ultrasound guide
- First Posted Date
- 2015-01-27
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 115
- Registration Number
- NCT02346929
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Treating Deep Seizure Foci With Noninvasive Surface Brain Stimulation
Not Applicable
Completed
- Conditions
- Epilepsy, Temporal Lobe
- Interventions
- Device: Sham repetitive transcranial magnetic stimulationDevice: Low-frequency repetitive transcranial magnetic stimulationDevice: High-frequency repetitive transcranial magnetic stimulation
- First Posted Date
- 2015-01-15
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 5
- Registration Number
- NCT02339376
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Completed
- Conditions
- Atrial FibrillationObstructive Sleep ApneaCardiac Arrhythmias
- Interventions
- Device: Home Sleep Testing Device
- First Posted Date
- 2015-01-06
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 130
- Registration Number
- NCT02332096
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Protective Effects of Propylene Glycol in Daily Acetaminophen Dosing
Phase 4
Completed
- Conditions
- Acetaminophen Toxicity
- Interventions
- Drug: First Treatment PeriodOther: WashoutDrug: Second Treatment Period
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2017-09-01
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT02322879
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Thiamine as an Adjunctive Therapy in Cardiac Surgery
Phase 2
Completed
- Conditions
- Coronary Artery BypassCardiac Surgical Procedures
- Interventions
- Drug: Normal saline solution
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 64
- Registration Number
- NCT02322892
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States